{"id":817556,"date":"2025-02-25T08:36:42","date_gmt":"2025-02-25T13:36:42","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\/"},"modified":"2025-02-25T08:36:42","modified_gmt":"2025-02-25T13:36:42","slug":"wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\/","title":{"rendered":"Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">CAMBRIDGE, Mass., Feb.  25, 2025  (GLOBE NEWSWIRE) &#8212; Wave Life Sciences Ltd.\u00a0(Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. ET on Tuesday, March 4, 2025, to review the company\u2019s fourth quarter and full year 2024 financial results and provide business updates.<\/p>\n<p>The webcast and conference call may be accessed by visiting \u201cInvestor Events\u201d on the investors section of the Wave Life Sciences website: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Q9MBQ5qU7OcO_Z72BS3cBVqlkXHkWfIUR-0MMqp1UoOUFjkHESu9keu11EToPPyjbHMO5y293X_kCU0FzqbaG6JPYOqmrVQy4Z9Bn7LfyaQEm_fqNwzQlUIRkr7Hhpe5pA6JC7RK5b695EgSFSePG0Wdz3V4xAWLpMw2pwg8jFExLBbY3A9FR42Hht0YRJQn\" rel=\"nofollow\" target=\"_blank\"><u>https:\/\/ir.wavelifesciences.com\/events-publications\/events<\/u><\/a>.<\/p>\n<p>Analysts planning to participate during the Q&amp;A portion of the live call can join the conference call at the following audio conferencing link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Gh9Bt6WC9GTt3FSCMZwra8zZ4viJEsl14QIIF5QHCIkdgXKNFFqd8NXd1iRzdkD2xJW6S1AXg-TugAYegcS3nqS7mR8s5gMeZI8A6COxPsXzbvcLwY6lpDxPstxu2yTA98TmOK-9ZCdhjlUt9_WzBQ==\" rel=\"nofollow\" target=\"_blank\"><u>available here<\/u><\/a>. Once registered, participants will receive the dial-in information.<\/p>\n<p>Following the live event, an archived version of the webcast will be available on the Wave Life Sciences website.<\/p>\n<p>\n        <strong>About\u00a0Wave Life Sciences<\/strong><br \/>\n        <br \/>Wave Life Sciences (Nasdaq: WVE) is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Wave\u2019s RNA medicines platform, PRISM<sup>\u00ae<\/sup>, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. Wave\u2019s diversified pipeline includes clinical programs in Alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy, Huntington\u2019s disease, and Obesity, as well as several preclinical programs utilizing the company\u2019s broad RNA therapeutics toolkit. Driven by the calling to \u201cReimagine Possible\u201d, Wave is leading the charge toward a world in which human potential is no longer hindered by the burden of disease. For more information on Wave\u2019s science, pipeline and people, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=G3nZLvzNzcLuz1zV8g3HXloTKG4s9U3B7V9NYm0Cx8TWaesL3bShULgX7E1S_01wgOqOhXTt2WSMbnbc6cQKzAxYyFDLHHOOto3Sc61ZjJU=\" rel=\"nofollow\" target=\"_blank\"><u>www.wavelifesciences.com<\/u><\/a> and follow Wave on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KnJuNh7s9DNrx5eCxP_IqSH_G-qbT6aXFZe_6Md7VxR5MfAy_u585muT5z0Yzb8IQKvLk1lR3bzD2LtbNZEN9w==\" rel=\"nofollow\" target=\"_blank\"><u>X<\/u><\/a> (formerly Twitter) and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=f4VVHOcr9sig5QqRN_zB2iFGKrWgTt_s7Bw_sG48-Mi8RiTGGSwpgiwU0OyQSqNuHktrv6FrLPYsGGRMjqYytkBug16O13VBT501uG0qfsyrhmtslL_jVmwAW7F8QStU\" rel=\"nofollow\" target=\"_blank\"><u>LinkedIn<\/u><\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Kate Rausch<br \/>+1 617-949-4827<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=i_7t7l2PlRP0TqD4TzNpbzWSHEIMJlf-cdUd0KWqrVUPQQP2QO7mgWFMkGS82gI7giSHFiZ-m49bhFLJ7h1ugxkWOuQSpnTQ2ttMFP0xJ80=\" rel=\"nofollow\" target=\"_blank\"><u>krausch@wavelifesci.com<\/u><\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Alicia Suter<br \/>+1 617-949-4817<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RDR6S8Q1OupRsfxI9QlFrdqhtTWWYyMDSoQcfSs5uociHtSi3ZqqRzGm0oswdBIFJMeuez302M0VrNQstISSWNBZw3E1d-h191q-xKpVN2E=\" rel=\"nofollow\" target=\"_blank\"><u>asuter@wavelifesci.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzg1MyM2Nzc2NDAyIzIwMjAyODg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ODA2YWVmYzctZDJiYy00NjBkLTliZDgtYzc0YmY2MjhhNzc1LTEwMzE4NjA=\/tiny\/Wave-Life-Sciences-USA-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) &#8212; Wave Life Sciences Ltd.\u00a0(Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. ET on Tuesday, March 4, 2025, to review the company\u2019s fourth quarter and full year 2024 financial results and provide business updates. The webcast and conference call may be accessed by visiting \u201cInvestor Events\u201d on the investors section of the Wave Life Sciences website: https:\/\/ir.wavelifesciences.com\/events-publications\/events. Analysts planning to participate during the Q&amp;A portion of the live call can join the conference call at the following audio conferencing link: available here. Once registered, participants will receive the dial-in information. Following &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-817556","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) &#8212; Wave Life Sciences Ltd.\u00a0(Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. ET on Tuesday, March 4, 2025, to review the company\u2019s fourth quarter and full year 2024 financial results and provide business updates. The webcast and conference call may be accessed by visiting \u201cInvestor Events\u201d on the investors section of the Wave Life Sciences website: https:\/\/ir.wavelifesciences.com\/events-publications\/events. Analysts planning to participate during the Q&amp;A portion of the live call can join the conference call at the following audio conferencing link: available here. Once registered, participants will receive the dial-in information. Following &hellip; Continue reading &quot;Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-25T13:36:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzg1MyM2Nzc2NDAyIzIwMjAyODg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025\",\"datePublished\":\"2025-02-25T13:36:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\\\/\"},\"wordCount\":341,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Mzg1MyM2Nzc2NDAyIzIwMjAyODg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\\\/\",\"name\":\"Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Mzg1MyM2Nzc2NDAyIzIwMjAyODg=\",\"datePublished\":\"2025-02-25T13:36:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Mzg1MyM2Nzc2NDAyIzIwMjAyODg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Mzg1MyM2Nzc2NDAyIzIwMjAyODg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\/","og_locale":"en_US","og_type":"article","og_title":"Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025 - Market Newsdesk","og_description":"CAMBRIDGE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) &#8212; Wave Life Sciences Ltd.\u00a0(Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. ET on Tuesday, March 4, 2025, to review the company\u2019s fourth quarter and full year 2024 financial results and provide business updates. The webcast and conference call may be accessed by visiting \u201cInvestor Events\u201d on the investors section of the Wave Life Sciences website: https:\/\/ir.wavelifesciences.com\/events-publications\/events. Analysts planning to participate during the Q&amp;A portion of the live call can join the conference call at the following audio conferencing link: available here. Once registered, participants will receive the dial-in information. Following &hellip; Continue reading \"Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-25T13:36:42+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzg1MyM2Nzc2NDAyIzIwMjAyODg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025","datePublished":"2025-02-25T13:36:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\/"},"wordCount":341,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzg1MyM2Nzc2NDAyIzIwMjAyODg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\/","name":"Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzg1MyM2Nzc2NDAyIzIwMjAyODg=","datePublished":"2025-02-25T13:36:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzg1MyM2Nzc2NDAyIzIwMjAyODg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzg1MyM2Nzc2NDAyIzIwMjAyODg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wave-life-sciences-fourth-quarter-and-full-year-2024-financial-results-scheduled-for-march-4-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/817556","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=817556"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/817556\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=817556"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=817556"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=817556"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}